5 Key Takeaways

• 1

  Idiopathic acute pancreatitis accounts for about 18% of global cases, with genetic testing and selective surgery reducing recurrence risk.

• 2

  Genetic testing can identify pathogenic variants in over 50% of younger patients with idiopathic acute pancreatitis or recurrent pancreatitis.

• 3

  Empiric cholecystectomy may lower recurrence rates, especially when occult biliary disease is detected, despite mixed evidence.

• 4

  Routine ERCP is not recommended for idiopathic acute pancreatitis due to risks of pancreatitis and mortality associated with the procedure.

• 5

  Current guidelines on genetic testing and management of idiopathic acute pancreatitis vary between the American College of Gastroenterology and the International Association of Pancreatology.